Effects of antitumor activity and protection of shock symptoms by a traditional Chinese medicine (Sho-saiko-to) in recombinant human tumor necrosis factor administered mice

Biological and Pharmaceutical Bulletin

Volumn 19, Issue 11, 1996, Pages 1474-1478

  Sakaguchi, Shuhei ^a   Furusawa, Shinobu ^a   Yokota, Katsushi ^a   Sasaki, Ken Ichi ^a   Takayanagi, Motoaki ^a   Takayanagi, Yoshio ^a  

^a TOHOKU PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

antitumor activity; Kampo medicine; preventive effect; Sho saiko to; shock symptom; tumor necrosis factor

Indexed keywords

ANTINEOPLASTIC AGENT; GLYCOGEN; NITRIC OXIDE; RECOMBINANT TUMOR NECROSIS FACTOR; XIAO CHAI HU TANG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CANCER INHIBITION; CANCER PREVENTION; CHINESE MEDICINE; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG POTENTIATION; GLYCOGEN METABOLISM; MALE; MOUSE; NONHUMAN; SARCOMA; SHOCK;

EID: 0029806203     PISSN: 09186158     EISSN: None     Source Type: Journal    
DOI: 10.1248/bpb.19.1474     Document Type: Article

References (24)

1. Fiers W., FEBS Lett., 285, 199-212 (1991).
2. Yamamura Y., "Recent Advances in the Pharmacology of Kampo (Japanese Herbal) Medicines," ed. by Hosoya E., Yamamura Y. Excerpta Medica, Tokyo, 1988, pp. 3-13.
3. Mizoguchi Y., Sakagami Y., Miyazima K., Yamamoto Y., Allergy, 35, 1119-1121 (1986).
4. Hasegawa I., Mizoguchi Y., Tsutsui H., Ichikawa Y., Kawada N., Morisawa S., Yamamoto S., J. Med. Pharm. Soc., 7, 24- 27 (1990).
5. Okita K., Kurokawa N., Yamasaki T., Gastroenterology (Tokyo), 12, 152-156 (1990).
6. Yano H., Mizoguchi A., Fukuda K., Haramaki M., Ogasawara S., Momosaki S., Kojiro M., Cancer Res., 54, 448-454 (1994).
7. Sakaguchi S., Tsutsumi E., Yokota K., Furusawa S., Sasaki K., Takayanagi Y., Microbiol. Immunol., 35, 389-394 (1991).
8. Sakaguchi S., Tsutsumi E., Yokota K., Biol. Pharm. Bull., 16, 782-786 (1993).
9. Sakaguchi S., Tsutsumi E., Yokota K., Biol. Pharm. Bull., 17, 232-236 (1994).
10. Sakaguchi S., Furusawa S., Yokota K., Sasaki K., Takayanagi Y., Biol. Pharm. Bull., 18, 621-623 (1995).
11. Yamada M., Furutani Y., Notake M., Yamagishi J., Yamayoshi M., Fukui T., Nomura H., Komiya M., Kuwashima J., Nakano K., Sohmura Y., Nakamura S., J. Biotech., 3, 141-153 (1985).
12. Wilder M. S., Sword C. P., J. Bacteriol., 95, 538-548 (1967).
13. Green L. C., Wagner D. A., Glogowski J., Skipper P. L., Wishnok J. S., Tannenbaum S. R., Anal. Biochem., 126, 131-138(1982).
14. Carmichael J., DeGraff W. G., Gazdar A. F., Minna J. D., Mitchell J. B., Cancer Res., 47, 936-942 (1987).
15. Moncada S., Palmer R. M. J., Higgs E. A., Pharmacol. Rev., 43, 109-142 (1991).
16. Kilbourn R. G., Griffith O. W., J. Natl. Cancer Inst., 84, 827-831 (1992).
17. Beutler B., Cerami A., Nature (London), 320, 584-588 (1986).
18. Kubo M., Matsuda H., Tani T., Arichi S., Kimura Y., Okuda H., Chem. Pharm. Bull., 33, 2411-2415 (1985).
19. Sasaki K., Murakami T., Oga A., Takahashi M., Okita K., Biotherapy, 3, 1515-1518 (1989).
20. Qain L., Okita K., Murakami T., Takahashi M., Biotherapy, 4, 1664-1670 (1990).
21. Feinberg B., Kurzrock R., Talpaz M., Blick M., Saks S., Gutterman J., J. Clin. Oncol., 6, 1328-1334 (1988).
22. Spriggs D., Sherman M., Michie H., Arthur K., Imamura K., Wilmore D., Frei E., Kufe D., J. Natl. Cancer Inst., 80, 1039-1044 (1988).
23. Bartsch H., Pfizenmaier K., Schroeder M., Nagel G., Eur. J. Cancer Clin. Oncol., 25, 287-291 (1989).
24. Lienard D., Ewalenko P., Delmotte J., Renard N., Lejeune F., J. Clin. Oncol., 10, 52-60 (1992).